Shikari® (S-ATG) Anti-Golimumab ELISA w/confirmation
GOL-QNS-SIM
Enzyme immunoassay for the quantitative determination of specific antibodies to Golimumab (Simponi®) in human serum and plasma.
This kit has been especially developed for the quantitative determination of golimumab in serum and plasma samples.
All SHIKARI® ELISA kits are produced under ISO 13485 quality system.
All SHIKARI® ELISA kits are produced under ISO 13485 quality system.
This kit has been especially developed for the quantitative determination of golimumab in serum and plasma samples.
The Matriks Biotek Antibody to Golimumab ELISA Kit can be efficiently used for monitoring anti-Golimumab antibodies during therapy and offers the clinician a tool for decision on possible preventive measures such as possible addition of immunosuppressive drug to reduce anti-Golimumab antibodies. Measurement of biological drug trough levels and antibody to biological drug gained high importance during the course of treatment. These measurements enable dose adjustments and switch to another class of biological drug when necessary.
All SHIKARI® ELISA kits are suitable for biosimilar work.
All SHIKARI® ELISA kits are produced under ISO 13485 quality system.
Research Use Only (RUO)
For technical inquiry, IFU and other relevant documents please contact techsupport@matriksbiotek.com
All SHIKARI® ELISA kits are produced under ISO 13485 quality system.
Research Use Only (RUO)
| Required Volume (µl) | 5 |
| Total Time (min) | 140 |
| Sample | Serum, plasma |
| Sample Number | 96 |
| Detection Limit (ng/mL) | 18,75 |
| Spike Recovery (%) | Between 85-115 |
| Shelf Life (year) | 1 |
| Assay type | Quantitative |
| Species Reactivity | Human |
| Storage conditions | Store at +4°C. Please refer to protocols. |
| Shipping conditions | At room temperature |
| # | File | Action |
|---|---|---|
| Safety Data Sheet (SDS) | Download |
Publications with this drug
| # | File | Action |
|---|---|---|
| Tawa, Hideki, et al. "Therapeutic drug monitoring of golimumab for the prediction of long-term clinical remission in patients with ulcerative colitis." Digestion 103.5 (2022): 329-338. | Visit Link | |
| Shibata, Hiroko, et al. "Evaluation of anti-drug antibodies against therapeutic monoclonal antibodies and related product in Japanese patients with rheumatoid arthritis and their clinical impact." European Journal of Pharmaceutical Sciences (2025): 107357 | Visit Link |
